February 3, 2026

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook on its 70% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech company based in San Diego, is capturing investor attention with its compelling growth potential in the rare endocrine diseases space. With a..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Exploring a 212% Upside Potential

For investors seeking high-growth opportunities in the healthcare sector, Viking Therapeutics, Inc. (NASDAQ: VKTX) presents a compelling case. With a market capitalization of $3.38 billion, this San Diego-based biotechnology company..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Powerhouse with a 71.70% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a key player in the healthcare sector’s diagnostics and research industry, is capturing investor interest with its robust market position and promising growth trajectory. Headquartered..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Gem with 54.57% Potential Upside

Immunovant, Inc. (IMVT), a compelling player in the biotechnology sector, is attracting significant attention from investors with a promising potential upside of 54.57%. Based in New York and a subsidiary..

Envista Holdings Corporation (NVST) Stock Analysis: Solid Revenue Growth Amidst Moderate Price Target

Envista Holdings Corporation (NYSE: NVST) has been carving its niche in the medical instruments and supplies industry with a focus on dental products. With a market capitalization of $3.87 billion,..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 33.49% Potential Upside Amid Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, particularly within the health information services industry. With a market capitalization of $2.88 billion, Privia Health’s innovative..

Haemonetics Corporation (HAE) Stock Analysis: A 39.86% Upside Opportunity for Savvy Investors

In the dynamic world of healthcare, Haemonetics Corporation (NYSE: HAE) stands out as a compelling player in the medical devices industry. With a market capitalization of $3.17 billion, this Boston-based..

Select Medical Holdings Corp (SEM) Stock Analysis: Potential Upside of 22% with Strong Buy Ratings

Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.87 billion, Select Medical is..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: A Promising Biotech with High Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a pioneering entity in the biotechnology sector, is capturing investor attention with its robust pipeline and strategic collaborations. Based in Pasadena, California, Arrowhead is committed..

Ligand Pharmaceuticals (LGND): Investor Outlook with 23% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with its robust financial metrics and a promising pipeline of biopharmaceutical assets. With a market capitalization of $3.9..

Concentra Group Holdings Parent (CON): Investor Outlook Reveals 28.99% Potential Upside

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) presents an intriguing prospect. Operating within the medical care facilities industry, Concentra offers a diverse array of..

Scholar Rock Holding Corporation (SRRK): Biotechnology Innovator with Promising Upside and Robust Buy Ratings

Scholar Rock Holding Corporation (NASDAQ: SRRK), a pioneering entity in the healthcare sector, is making significant strides in the biotechnology industry with a focus on developing transformative therapies. Headquartered in..

PTC Therapeutics (PTCT) Investor Outlook: An 18% Upside Potential Amidst Robust Pipeline

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its strategic focus on rare disorders and a promising pipeline...

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with a 10.5% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning entity within the biotechnology sector, is capturing investor attention with its promising portfolio of therapies targeting rare and orphan diseases. Based in Foster..

Vericel Corporation (VCEL): Stock Analysis Reveals a Promising 48.89% Upside Potential

Investors in the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing opportunity, as the company presents significant potential upside in its current market position. With a market cap..

NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside

For investors with an eye on the healthcare sector, NewAmsterdam Pharma Company N.V. (NAMS) offers a captivating opportunity. This Netherlands-based biotechnology firm, with a market capitalization of $3.58 billion, is..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 44% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector with a notable focus on behavioral healthcare services across the U.S. and Puerto Rico. With a market capitalization..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Assessing Growth Potential with an 18% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotechnology sector, has been attracting attention with its innovative approach to treating inflammatory diseases. As a clinical-stage biotech company based in..

ICU Medical, Inc. (ICUI) Investor Outlook: Analysts Signal a 19.4% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI) is at the forefront of the healthcare sector, specializing in the production and distribution of innovative medical devices used in infusion therapy, vascular access, and..

Warby Parker Inc. (WRBY) Stock Analysis: A Visionary Growth Story with 15.20% Revenue Surge

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, continues to capture investor attention with its innovative approach to eyewear and eye..

Search

Funds

February 3, 2026

Search

Funds

February 3, 2026

FTSE 100

Funds